Allergan Inc., maker of wrinkle treatment Botox, is challenging the government's ban on marketing off-label uses for pharmaceuticals. In a lawsuit filed Thursday, the Irvine company argued that it should...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Botox maker seeks to lift U.S. ban on marketing unapproved uses
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account